Andrew Roddam

Andrew Roddam has extensive work experience in the field of data strategy, design, and epidemiology. Andrew is currently the Chief Executive Officer at Our Future Health UK, a position they have held since April 2020. Prior to this, they worked at GSK from 2013 to 2020, where they held various roles including Vice President of Data Strategy & Design, Data & Computational Sciences, and Vice President & Global Head of Epidemiology & RWE. In these roles, they led a team of around 80 people and implemented epidemiology and real-world evidence strategies to support the safety and effectiveness of the company's medicines. Before GSK, they had roles at Amgen as the International Head of the Center for Observational Research and Head of International Epidemiology from 2009 to 2013. Earlier in their career, they worked as a Statistical Epidemiologist at the University of Oxford from 2002 to 2008.

Andrew Roddam obtained a Bachelor of Science with Honors degree in Mathematics and Statistics from the University of Warwick, where they studied from 1992 to 1995. Following this, they pursued a DPhil degree in Statistics at the University of Oxford, from 1995 to 1998.